Welcome Guest
Sign In
Register
Home
Bioprocessing
Chromatography
Drug Delivery
Excipients
Formulation Development
Microbiology
Spectroscopy
Articles
Issue Archives
Whitepapers / App Notes / eBooks
Infographics
Facility Tour
CGT Circuit
News
Industry News
Supplier News
All News
Products
Featured Products
New Products
Analytical Equipment
Formulation Development
Pharmaceutical Manufacturing
Excipients
All Other Products
QC Corner
Webinars
Videos
Documentaries
Company Profiles
Events
Register
Sign In
Home
Bioprocessing
Product Center
Bioprocessing - Subhome
Pharmaceutical Filtration
Pharmaceutical and Bioprocess Filtration Systems
Pharmaceutical and Bioprocess Filtration Systems
Bioprocess filtration is a fundamental downstream bioprocessing process which aims to remove impurities such as cell debris, viruses, and other bacteria from cultures to help ensure the sterility of biopharmaceuticals. Bioprocess filtration is typically achieved using a several step process, with methods ranging from tangential flow to ultra or nanofiltration. With products ranging from entire automated bioprocess filtration systems to consumables such as filters and tips, the right bioprocess filtration products can help increase throughput and compliance in pharmaceutical labs and research facilities.
Showing 2 of 2 products
<<
<
>
>>
Sort By
- select -
Item Name
Company Name
Get quotes for all products
Select All
Select up to 5 products from below to compare or request more information.
Compare
Samplicity Filtration System
MilliporeSigma
Pharmaceutical Application:
Use with aqueous acid and base solutions, alcohols, acetonitrile, and 10% organic solvents in water
Pore Size:
0.2 or 0.45 um
Filtration Area:
Inquire
Get quote
Compare
or
Get quote
for selected.
Select All
Select up to 5 products from above to compare or request more information.
Compare
Companies that sell Pharmaceutical and Bioprocess Filtration Systems
Sartorius AG
Goettingen
,
Germany
Tags:
Please Login or Register to Create Tags
Feedback
Articles
Filtration Systems: In Design and Practice
SARTOFLOW Alpha plus SU Filtration System
AbbVie Completes Acquisition of ImmunoGen
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
Charles River Extends Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Getting to GMP-Quality Biotherapeutics From Today’s Bench-Scale Continuous Manufacturing Systems: A Gap Analysis
ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic Fever
Battling Exorbitance: High Costs in Sickle Cell Gene Therapies and the Imperative of Global Patient Registries for Equity
Myrtelle's rAAV-Olig001-ASPA Gene Therapy Candidate Receives RMAT Designation from the FDA
Bioprocess Controller for Microbial Applications
Biognosys and Alamar Biosciences Form Proteomics Partnership to Advance Biopharma and Precision Medicine Research
Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
Viral Vector Process Development and Manufacturing
First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ
ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases
WACKER Expands Production Capacity for Biopharmaceuticals in San Diego
ProBio Expands Plasmid DNA and Viral Vector Production in New Jersey to Accelerate Delivery of Life-Changing Cell and Gene Therapies
Peptide Synthesis Market Size Set to Reach $5.1 Billion in 2035
Zealand Pharma Appoints Eric Cox as Chief Commercial Officer
SK pharmteco and Rznomics Explore Collaboration for RNA-based Gene Therapy Development and Manufacturing
UCLA Receives $120M Grant for New California Institute for Immunology and Immunotherapy
Ascend Adds New Fill/Finish Capabilities for Gene Therapy
AzurBio Pharma Launches to Fast-Track European Market Entry for Biopharma Companies
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy from Curon Biopharmaceutical
Tevogen to Develop Genetically Unmodified T Cell Therapeutic to Treat HPV in Women with Precancerous Cervical Lesions
OmniaBio Opens Cell and Gene Therapies Manufacturing Facility in Canada
Continuing Momentum in Bioconjugate Therapeutics with Advanced Linker Chemistry
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
FDA Approves Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
AlveoGene Receives FDA Rare Pediatric Disease Designation for Inhaled Gene Therapy
Rgenta Therapeutics Partners with GSK to Develop RNA-Targeted Small Molecule Splice Modulators
Merck Partners with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist
Asahi Kasei Pharma Announces License Agreement for Anti-CX3CR1 Antibody
Rentschler Biopharma Withdraws from Cell and Gene Therapy Market
The Future of Bispecific Antibodies
ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger
Canadian Government to Invest in Biomanufacturing Capacity
AbbVie and ADARx Pharmaceuticals to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas
Rznomics Enters Global Licensing Agreement with Eli Lilly for RNA-editing Therapeutics
AbbVie and U of T Mississauga's SpinUp Name First Winner of AbbVie Biotech Innovators Award
Hansa Biopharma to Lay Off 20% Amid Restructuring
Aizon and Sequence Partner to Transform Biopharmaceutical Manufacturing with AI-Powered Solutions
Advances in Ionizable Lipid Design: Accelerating mRNA Therapeutic Development Through Rapid Optimization Platforms
Pharmaceutical P.I.N. Points: Patent Innovation News
FDA Accepts BLA for Proposed Biosimilar to Simponi® and Simponi Aria®
FDA Approves AMVUTTRA® an RNAi Therapeutic to Reduce Cardiovascular Death
Artis BioSolutions Acquires Landmark Bio to Expand Manufacturing and Commercialization of Advanced Therapies
Ethris and Lonza to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention
Integrated Multi-Omic Data: Powering Precision Medicine
Awakening the Giant: The Next Frontier in mRNA Therapeutics
Mechanistic Modeling: Biotechnology Manufacturing
China Approves Its First IGF-1R Monoclonal Antibody
FDA Approves CRENESSITY™ for Children and Adults With Classic Congenital Adrenal Hyperplasia
Driving Innovation in Antibody Therapeutics, From Basic Research to the Clinic
Executive Q&A: Biopharmaceuticals/ Biosimilars
FDA Grants Orphan Drug Designation to EXG110, a Novel Gene Therapy for Fabry Disease
Samabriva Opens Large-Scale Biomanufacturing Facility in Belgium
FDA Grants Breakthrough Therapy Designation to Treatment for Chronic Hepatitis D Virus Infection
Executive Q&A: Samsung Biologics
BioNTech Acquires Biotheus for $800M
NIIMBL Releases Action Plan for Increasing Flexibility of Antibody Manufacturing for Rapid Response
CAR-T-Similars: Will We See Future Biosimilar Versions of CAR-T Therapies?
Customized Antibodies – Vehicles for Therapeutic Success
Editas Medicine and Genevant Sciences to Collaborate to Develop Novel mRNA-LNP Gene Editing Therapeutics
Legend Biotech to Establish Cell Therapy Research and Development Facility in Philadelphia, PA
AstraZeneca Licenses Lipid Lowering Lp(A) Asset
GBI Biomanufacturing and Allterum Therapeutics to Manufacture Therapeutic Antibody for Clinical Trials
Dark Horse Consulting Group Acquires BioTechLogic
J&J Seeks Approval of Nipocalimab to Treat Antibody Positive Generalized Myasthenia Gravis
Longeveron® Meets With FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS)
NSG BioLabs and Merck Collaborate to Support Biotech Start-ups to Advance Research & Innovations
Ascend Strengthens Gene Therapy Development with Two New Executive Hires
FDA Approves First Gene Therapy to Treat Adults with Metastatic Synovial Sarcoma
SCG Cell Therapy Announces FDA IND Clearance of T-cell Therapy for HPV-Associated Solid Tumors
Johnson & Johnson Completes Acquisition of Yellow Jersey Therapeutics
MyMD Pharmaceuticals Rebrands to TNF Pharmaceuticals, Inc.
FDA Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
Walgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business
Delivery of Antibody Drug Conjugates via Lipid Nanoparticles
AC Immune and Takeda Sign License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
EPA, FDA, and USDA Issue Joint Regulatory Plan for Biotechnology
FDA Approves RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche
TriLink and Lonza Enter Partnership for CleanCap® mRNA Capping Technology
Astellas and Poseida Therapeutics Collaborate to Develop Novel Allogeneic Cell Therapies in Oncology
Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
Charles River to Perform Plasmid Production for Ship of Theseus
Ipsen and Sutro Biopharma Announce Global Licensing Agreement for an ADC Targeting Solid Tumors
Alys Pharmaceuticals Launches with $100M Financing to Advance Immuno-Dermatology Focused Pipeline
AbbVie and Tentarix to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology
Akari Therapeutics and Peak Bio Announce Merger Agreement
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
Astellas and Kelonia Therapeutics to Develop Novel Immuno-Oncology Therapeutics
Adimab Announces Substantial Expansion of Research Campus
PDA Ireland Chapter Meeting Focuses on Microbiology as the Key to Compliance to Annex 1 and Risk Based Regulation
Driving Breakthroughs in mRNA Therapeutics with Advanced Analytical Techniques
ProBioGen Granted a New Patent for DirectedLuck Transposase Tech
FDA Extends Review of BioMarin’s ROCTAVIAN Gene Therapy for Adults with Hemophilia
Northwest Biotherapeutics and Advent BioServices Receive License for Commercial Manufacturing at Sawston, U.K. Facility
Aseptic Process Simulation: Cell and Gene Therapy Manufacture
CEL-SCI Commissions Multikine Manufacturing Facility for Commercial Production of Head & Neck Cancer Drug
FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma
Merck Completes Acquisition of Harpoon Therapeutics, Inc.
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
Real-Time Analytics in Automated Cell Therapies Manufacturing
Cancer Biomarkers Market Worth $42.0 Billion
Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland
Ask an Expert: How Can I Master the Art of Formulation with Biologically Derived Ingredients?
MIP Discovery Rebrands as Tozaro to Support Cell And Gene Therapy Viral Vector Analytics And Purification
Pfizer and BioNTech Receive FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
Predicting Global Trends in Biomanufacturing in 2025 at CPHI Milan
VERDOT to Construct New Headquarters and Manufacturing Facility in Riom, France
Dyadic Receives $3M Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
Sartorius Stedim Biotech and Tulip Partner to Drive End-to-End Biomanufacturing Visibility and Optimization
AstraZeneca Completes Gracell Acquisition
Uniting Quality Expectations on Reinvigorated Biopharma Campuses
Theradaptive Awarded DOD Clinical Trial Award of up to $7.4M
Novo Nordisk Foundation Partners with CARB-X to Fight Drug-Resistant Infections
Biopharmaceuticals and Biosimilars
Cellipont Bioservices Opens Purpose-Built Cell Therapy Manufacturing Facility
Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership with eXmoor pharma
BMS’ CAR T Cell Therapy Breyanzi Approved by the FDA for Relapsed or Refractory Follicular Lymphoma
PulseSight Therapeutics to Advance Non-viral Gene Therapies with Disruptive Minimally-Invasive Delivery Technology for Severe Retinal Diseases
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the Foundation for the National Institutes of Health AMP Bespoke Gene Therapy Consortium
Microbial Considerations for the Selection of Aseptic Connectors
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
Caris Life Sciences Partner with Merck to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair
Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs
Multiply Labs and Retro Biosciences Partner to Advance Cell Therapy Manufacturing for Age-Related Diseases
KromaTiD Expands Their Gene Therapy Analytic Assay Suite with the Addition of GLP Genomic Integrity Karyotyping Services
AstraZeneca Expands US Manufacturing Footprint to Accelerate Next-Generation Cell Therapy Discovery and Development
Macomics Announces Appointment of Simon Dew as New Chief Business Officer
mRNA and Oligonucleotides Process and Manufacturing
Unlocking Affordability: How Global Patient Registries Transform Affordability of Cell/Gene Therapies
FDA Grants Fast Track Designations to Caribou Biosciences’ CAR-T Cell Therapies
The Bioprocess Revolution: How Technology and Trends are Reshaping Pharmaceutical Manufacturing
FDA Releases Agenda for Rare Diseases Innovation Hub
BioNet Wins BARDA Patch Forward Prize for Microneedle mRNA Vaccine Innovation
SOPHiA GENETICS Expands Liquid Biopsy Testing Collaboration with AstraZeneca
NovelMed Receives FDA IND Approval for Ruxoprubart for Renal Disorder
Pfizer and BioNTech Provide Update on Phase III Trial of mRNA-based Combination Vaccine Program Against Influenza and COVID-19
evitria and Lonza Sign License Agreement to Provide Fast Access to bYlok® Bispecific Antibodies for Discovery-Stage Transient Expression Research
Vaccines Market Worth $94.9 Billion
Portal Biotechnologies and Multiply Labs Partner to Automate Cell Engineering In Cell Therapy Manufacturing
Endogenous Mechanisms for Nanoparticle-Based Nucleic Acid Delivery
Using Rapid Microbiological Methods Flexibly to Ensure Safe Cell and Gene Therapeutics
App Note: To GMP or not to GMP? That is the (PLASMID) question
How SGS Supports Cell & Gene Therapy Manufacturing
Subscriptions
Get started here for your complimentary
print or digital subscription
Sign up Now »
Featured Products
HyClone CCM5 Cell Culture Media
BD Select BD Cell Hybridoma MAb Medium - Quantum Yield
APAF-BP AdvantaFlex™ Biopharmaceutical Grade TPE Tubing
Connect with Us